Enanta Pharmaceuticals (ENTA) Other Gross PP&E Adjustments (2016 - 2025)
Historic Other Gross PP&E Adjustments for Enanta Pharmaceuticals (ENTA) over the last 14 years, with Q4 2025 value amounting to -$37.8 million.
- Enanta Pharmaceuticals' Other Gross PP&E Adjustments fell 33029.21% to -$37.8 million in Q4 2025 from the same period last year, while for Dec 2025 it was -$37.8 million, marking a year-over-year decrease of 33029.21%. This contributed to the annual value of $20.3 million for FY2025, which is 70225.65% up from last year.
- As of Q4 2025, Enanta Pharmaceuticals' Other Gross PP&E Adjustments stood at -$37.8 million, which was down 33029.21% from $20.3 million recorded in Q3 2025.
- In the past 5 years, Enanta Pharmaceuticals' Other Gross PP&E Adjustments registered a high of $20.3 million during Q3 2025, and its lowest value of -$37.8 million during Q4 2025.
- Moreover, its 5-year median value for Other Gross PP&E Adjustments was -$9.1 million (2021), whereas its average is -$8.4 million.
- Examining YoY changes over the last 5 years, Enanta Pharmaceuticals' Other Gross PP&E Adjustments showed a top increase of 70225.65% in 2025 and a maximum decrease of 33029.21% in 2025.
- Enanta Pharmaceuticals' Other Gross PP&E Adjustments (Quarter) stood at -$19.4 million in 2021, then dropped by 21.32% to -$23.5 million in 2022, then increased by 9.33% to -$21.3 million in 2023, then surged by 176.98% to $16.4 million in 2024, then tumbled by 330.29% to -$37.8 million in 2025.
- Its last three reported values are -$37.8 million in Q4 2025, $20.3 million for Q3 2025, and $19.6 million during Q2 2025.